H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.5% of adults in Sioux Falls have diagnosed diabetes — 1.5 points below the U.S. 12% figure. Census population 192,517. South Dakota Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Sioux Falls clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Sioux Falls storefront.
Wharton's Jelly Allograft Products in Sioux Falls, SD for clinics & physicians. Wharton's jelly allografts… Compliance support & pricing — contact Hawk Medical.
Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 10.5% of adults in Sioux Falls have diagnosed diabetes — 1.5 points below the U.S. 12% figure. 8.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick whartons jelly allograft against that mix.
National Wharton's Jelly Allograft Products notes (how the product actually works)CDC PLACES (2023, crude) estimates 10.5% of adults in Sioux Falls have diagnosed diabetes — 1.5 points below the U.S. 12% figure. Adult obesity in Sioux Falls is 36.9% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 22.7% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JF / Noridian Healthcare Solutions, sibling states AK, AZ, ID, MT, ND, OR, UT, WA, WY. South Dakota Department of Health is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a Sioux Falls warehouse or a five-star local review. What you get is whartons jelly allograft from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JF, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 10.5% of adults — 1.5 points below the U.S. 12% figure. Obesity is 36.9%; arthritis is 22.7%. That is place-level BRFSS modeling, not a clinic census and not a Sioux Falls trial.
No. Noridian Healthcare Solutions writes coverage. We train staff on documentation patterns those articles already require (wound measurements, conservative care, units). That is support, not a coverage guarantee.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. Noridian Healthcare Solutions LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
If you operate in South Dakota and another MAC state, say it on the first call. JF will not port 1:1. We would rather split utilization than watch a sister clinic copy Sioux Falls tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Sioux Falls, SD.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Sioux Falls is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Sioux Falls — 1.5 points below the U.S. 12% figure. Planning input, not an outcomes claim.
South Dakota Part B wound biologics follow this contractor (siblings: AK, AZ, ID, MT, ND, OR, UT, WA, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Sioux Falls. Useful for joint-program math; still needs a diagnosis and privileging.
No Sioux Falls storefront. Joe Bradley is an active practice owner. whartons jelly allograft stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.